Sandostatin, also known by its generic name octreotide, is a synthetic analogue of the natural hormone somatostatin. It is primarily used in the management of severe diarrhea and flushing episodes associated with certain types of tumors, such as carcinoid tumors and vasoactive intestinal peptide tumors (VIPomas). Additionally, Sandostatin is utilized in the treatment of acromegaly, a condition characterized by excessive growth hormone production, leading to abnormal growth of body parts. It works by inhibiting the secretion of several hormones and substances in the body, including growth hormone, insulin, and gastrin, thereby helping to control symptoms associated with these conditions. Sandostatin is available in injectable forms, including both short-acting and long-acting formulations, allowing for flexibility in dosing and administration based on the patient's needs and the specific condition being treated.